Table 5.
Cat | B | D3 | D7 | D14 | D30 | D60 | D90 | D120 |
---|---|---|---|---|---|---|---|---|
Group R-M | ||||||||
LC11 | 5.4 | 4.4 | 5.7 | 12.6 | 18.9 | 11.7 | 5.9 | 7.3 |
LC12 | 9.6 | 8.2 | 4.7 | 18.2 | 23.4 | 14.1 | 7.9 | N/A |
FO5 | 2.0 | 8.1 | 16.8 | 3.6 | 5.9 | 6.6 | 2.7 | 3.9 |
Group R-L | ||||||||
FO4(1) | 91.8 | 97.1 | 192.9 | 99.4 | 78.8 | 46.4 | 65.6 | 80.8 |
FO4(2) | 80.8 | 65.4 | 56.1 | 49.2 | 51.9 | 74.8 | 79.2 | 83.1 |
VJ3 | 3.7 | 5.2 | 8.4 | 5.0 | 4.9 | 4.6 | 3.3 | 4.4 |
Group C | ||||||||
FO2 | 19.0 | 22.5 | 29.4 | 48.2 | 79.3 | 37.5 | 39.5 | 46.8 |
FO3 | 7.3 | 4.5 | 5.3 | 10.1 | 16.4 | 12.9 | N/A | 19.7 |
MO1 | 7.1 | 12.7 | 17.3 | 29.3 | 10.4 | 20.5 | 41.4 | 46.5 |
VJ4(1) | 10.4 | 11.7 | 14.7 | 54.4 | 66.0 | 62.6 | 61.7 | 54.9 |
VJ4(2) | 54.9 | 57.1 | 51.4 | 49.6 | 63.7 | 55.8 | 57.5 | 51.6 |
Baseline of the second lesion was taken from data of 4-month after first lesion.
(1) and (2): the first and second VMPJ lesions.
N/A: data were not available.